“I call it the machine behind the scenes” – a conversation with Nassib Chamoun

Nassib Chamoun, HDAI’s founder, president and CEO, recently recorded a podcast with Slice of Healthcare’s Jared Taylor. They talked about Nassib’s background, AI’s role in healthcare and how HDAI’s analytics improve clinical and financial results. A link to the recording and a transcript of the conversation are below. The transcript of the conversation has been edited for length and clarity.

Jared Taylor: Nassib, tell us about your background.

Nassib Chamoun: I’m a healthcare entrepreneur. I’m a Lebanese immigrant, and I came to Boston about 40 years ago. I did my schooling at Northeastern University, did my graduate school at Boston University and the Harvard School of Public Health, and dropped out to start my first medical device company, which I ran for about 23 years, both as a private and public company.

I’ve been doing AI and machine learning and analytics in healthcare since then.  About five years ago, I started the Health Data Analytics Institute. I took a short stint running a quantitative hedge fund, but I love healthcare a lot better.

Jared Taylor: And you were utilizing AI before it was cool?

Nassib Chamoun: Absolutely. I’ve been focusing on it literally since computers were used to analyze healthcare data, and it’s been a blast since, and it keeps getting better.

Jared Taylor: Now everyone’s great uncle knows or has heard of AI.

Nassib Chamoun: Everybody’s talking about it today.

Jared Taylor: Give us an overview of what you’re working on today and what really excites you about the company.

Nassib Chamoun: What HDAI is all about is trying to understand how we take all the data that’s out there and make it work for the clinicians in healthcare.

A lot of work has gone into collecting the data, warehousing the data, not unlike what OpenAI has done with what’s on the web. There’s tons of data out there. How do you organize it? How do you curate it? How do you make this information work for those who need it when they need it during the care of their patients?

HDAI is an enabling platform and technology that allows clinicians across the continuum of care to access the information they need, in a format that’s easy to digest, that’s very efficient, that gets them to focus on the patients who need more of their attention.

So, we’re not trying to solve a clinical problem. I think it’s more operational. You have too many patients, too much data, too little time. How do you get to what you need to do to do your job as a clinician, whether you’re a nurse, a doctor, a care coordinator, or even an administrator trying to understand what’s going on within your organization?

So, we bring all those pieces together and we help organizations first understand what’s working and what’s not working for them by using AI to analyze all the dimensions of cost, outcomes, and utilization. And then we use those same models and help them deploy them through our technology platform at the point of care so they can start to move the needle and change how they do things. That’s the big picture.

Jared Taylor: Where do you see AI’s role continuing to evolve, in your particular business but also in healthcare more broadly?

Nassib Chamoun: I think it will be an evolution, and today I’d say the most critical and pressing role is how to operationalize the data we have and make it deliver the kind of information that helps clinicians target the patients that need their attention, helps administrators understand where the information can help them optimize their efficiency, and helps patients understand the risks they have and the kind of care they should seek.

Ultimately, there is a transition of AI doing more, but there’s so much to do right now that hasn’t been done. If you look at healthcare, we’re way behind any industry in bringing this kind of capability to the day-to-day care management of patients and how we can make their lives better and how we can make their outcomes better through this technology.

Jared Taylor: It will be interesting to see how things continue to progress with AI in healthcare. When it comes to accountable care organizations [ACOs], using analytics to improve clinical and financial fronts, what are some of the best ways for them to do that? What are some suggestions on how they should be using analytics?

Nassib Chamoun: For accountable care organizations today, a lot of the analytics they do are top-down analytics. They take a group of patients and say, “So many of them went into the emergency room or had an unplanned admission or had a complication of some sort or went into a skilled nursing facility.” To manage this population, they tend to break them into buckets based on chronic conditions – – segmentation through utilization. You look at the past, you see what went on with patients, and you put them in these big buckets and start to focus on them.

The problem with that is these segments are intertwined. There are too many of them, and the intersections are complicated. Before you know it, you either create big buckets that consume a lot of resources where a few patients in a bucket may need your attention, or very small buckets that focus on very high-risk patients, but you miss a lot of other people.

Where AI and machine learning come into play is how do we take the full universe of patients and look forward to who’s likely to experience an adverse event, who’s likely to require a certain procedure or a visit with the doctor? These models look at all the pieces that happened in the past and the likelihood of something happening in the future. They guide better targeting and focus on the areas you’re trying to address without having to manually figure it out.

Today, it’s been advanced dramatically through these types of AI and machine learning algorithms to make it much more focused and targeted. It allows you to really manage your full population. I call it the machine behind the scenes. It’s going through the records of your patients all the time, and understanding what happened to them, what new conditions have emerged, and, more important, what’s likely to emerge in the future. And putting them in front of the clinicians in a way that allows them to apply their skills and expertise to manage those patients more effectively.

The goal is not to play doctor. The goal is to make the clinicians, the nurses, a lot more efficient and targeted in what they do because resources are limited, patients are getting older and sicker, and they require more attention. How do you distribute that in the world today?

I was at a meeting yesterday at one of the major medical centers, where I serve on the board, and they said nursing costs in Boston went from $200 million for visiting nurses to $1.5 billion last year. How do you deal with that and still deliver the care that patients need? Technology can help.

Jared Taylor: That’s really interesting. What gaps or challenges still exist in the analytics field that you would like to see us get past in the near future?

Nassib Chamoun: I’ll start with one of my favorite quotes, from the head of analytics at a major health system that we work closely with. He said, “We do the right things for our patients, but we do them randomly.” What he meant by that is clinicians, health systems, and ACOs are all committed to doing the best for their patients. The question is, are they able to identify all the patients who require that extra level of attention and give it to them? Or is the care they’re delivering kind of diffuse across the full population?

Today, if you look at the data and the patients who have adverse events, complications, or need certain labs, testing, or screening, and you look at the likelihood of them needing it or the risk of them having that event relative to the resources allocated to those patients, it’s relatively flat. Which says that in order to figure things out, we have to touch a lot of people and try to find our way through it.

AI can really do a lot of the legwork behind the scenes and try to address, for example, who are the patients who should be screened by a certain test and how frequently that should happen. It doesn’t mean that the clinician should do it, but can I surface to the top, the 10 patients you look at and the two or three that you end up proceeding with the testing. Who’s likely to end up in the emergency room? Maybe we should call them and bring them in for some periodic checks.  You’re not going to eliminate all these events, but you can focus on the patients who need the care versus patients who want the care.

A lot of us fall into the “worried well” category and we go to the doctor just as a safety check. But many don’t, and many are percolating out there, progressing towards a bad outcome, and they go unnoticed because doctors’ offices are answering the phone from people like you and me who call and go in to see them routinely.

How can we bring these other patients in and make sure they get the care they need before their condition deteriorates, it gets more expensive, the outcome is bad for them, the cost is high for the system, and the human resources required to take care of them are increasing at a rate that we can’t meet today? That’s where AI can help.

Jared Taylor: What’s next for you and the company that you’re really excited about?

Nassib Chamoun: I think there are a lot of myths about AI out there. People think it’s either a silver bullet or something that’s really bad that’s going to disadvantage patients and society. I’m very optimistic about what we can do to help dispel these myths and bring reality to the table. We think if we had more modest expectations of what AI and machine learning can do for us, everybody’s going to make enormous progress forward.

So, it’s not about the models, it’s not about AI per se. It’s about how do we take AI and integrate it into the care pathways and the workflows that clinicians have in place today? How do we change the paradigm of operating in the healthcare system with the assistance of these tools?

A lot of the resources that HDAI is spending and investing in today are less about the AI itself and more about: how do I merge this information with everything else that clinicians are doing in a way to improve their workflows, their pathways, and ultimately the process by which they care for patients? Succeeding with that and helping everybody transition to that is ultimately what’s going to create and drive value.

So, it’s not the model, it’s not the tool itself. It’s how you operationalize this tool and put it in the hands of the various stakeholders in the healthcare process to make sure it serves the patients end-to-end. It’s not just about the doctor. It’s the patient, it’s the nurse that takes your information, it’s ultimately the care coordinator that’s organizing what’s going to happen. It’s those that are in a hospital caring for that patient during and after they get discharged from the hospital. How can we give them the thread of information that’s consistent, so everybody’s taking the same actions and ultimately making a difference for that patient?

Jared Taylor: Well, I want to thank you once again for joining me on the podcast today.

Nassib Chamoun:
Thank you so much. Great being here with you today.

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray VP Analytic Services

Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.

Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain Chief Product Officer

David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.

Margie Ahearn
VP HR

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO

Nassib is a data scientist, lover of logistical regression and a serial entrepreneur. Previously, he was Founder and CEO of Aspect Medical Systems, a Nasdaq traded company now owned by Medtronic. Outside of work, he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture

1

We are driven to make a profound impact on US healthcare

2

We operate in the best interests of patients and those who serve them

3

We understand and protect patient privacy and health information security

4

We use data science to enhance, but never replace clinical expertise and judgment

5

We are committed to continuous learning and improvement

6

We bring rigor, discipline, and reliability to our work

7

We start with kindness, assuming good intent in others

8

We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated

9

We are committed to the well-being of our employees and their families

Our vision

We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, which will improve the health of individuals and populations.

Our mission

Deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.

Who we are

We collaborate with leading health systems and integrated delivery networks, value-based care and accountable care organizations, physician groups, and commercial payers to improve care delivery and population health while reducing costs and making efficient use of scarce clinical resources.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.